Sherbrooke Park Advisers’s 4D Molecular Therapeutics FDMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-15,578
Closed -$327K 1005
2024
Q2
$327K Buy
+15,578
New +$327K 0.06% 585